🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Primary Immunodeficiency (PID)

Studies of Disorders With Increased Susceptibility to Fungal Infections NCT01222741n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders NCT07261891NA1 site📍 Leuven prof. dr. Rik Schrijvers · Tests: blood sampling COVID-19 in PID Survey NCT04459689n/a1 site📍 Paris Imagine Institute A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency NCT06565078n/a1 site📍 Tokyo Takeda · Tests: Immune Globulin Subcutaneous (Human), 20% Solution Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID) NCT07346859Phase 312 sites📍 Cherkasy📍 Chernivtsi📍 Ivano-Frankivsk Biopharma Plasma LLC · Tests: BP-SCIG 20% Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies NCT02735824n/a1 site📍 Zurich University Children's Hospital, Zurich · Tests: Skin Biopsy, Mouth Swab or Saliva Collection, Blood Sampling Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts NCT04691622Phase 13 sites📍 Washington D.C.📍 Baltimore📍 Bethesda Children's National Research Institute · Tests: Norovirus -specific T-cell (NST) therapy V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency NCT06954441Phase 31 site📍 Recife On Pharma Importadora, Exportadora e Distribuidora de Medic… · Tests: Intravenous immunoglobulin (IVIG) Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy